PHARMAQ ANALYTIQ AS

5006 BERGEN

Finances

Return on Equity

−23,23 %

Current Ratio

0,92

Debt-to-Equity Ratio

0,02

Key figures (NOK)	2022	2021	2020	2019
Revenue	78 756 000	82 604 000	55 429 000	49 560 000
Net Income	−4 847 000	−2 989 000	−4 281 000	−953 000
Total Assets	50 285 000	57 212 000	49 527 000	39 589 000
Total Equity	20 862 000	20 256 000	13 127 000	12 153 000

Income (NOK)	2022	2021	2020	2019
Revenue	78 756 000	82 604 000	55 429 000	49 560 000
Expenditure	84 654 000	86 234 000	60 819 000	50 469 000
Operating Profit	−5 898 000	−3 631 000	−5 390 000	−908 000
Financial Income	5 000	−147 000	9 000	100 000
Financial Costs	485 000	82 000	103 000	414 000
Financial Balance	−480 000	−229 000	−94 000	−314 000
Earnings Before Tax	−6 379 000	−3 861 000	−5 485 000	−1 222 000
Tax	−1 532 000	−872 000	−1 203 000	−269 000
Net Income	−4 847 000	−2 989 000	−4 281 000	−953 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	23 522 000	26 919 000	21 991 000	21 642 000
Total Current Assets	26 763 000	30 293 000	27 536 000	17 947 000
Total Assets	50 285 000	57 212 000	49 527 000	39 589 000
Total Retained Equity	7 821 000	12 668 000	12 227 000	11 253 000
Total Equity	20 862 000	20 256 000	13 127 000	12 153 000
Total Long-Term Debt	421 000	415 000	609 000	330 000
Total Current Debt	29 002 000	36 541 000	35 791 000	27 107 000
Total Equity and Debt	50 285 000	57 212 000	49 527 000	39 589 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	78 737 000	82 604 000	55 367 000	49 560 000
Other Income	18 000	0	62 000	0
Revenue	78 756 000	82 604 000	55 429 000	49 560 000
Cost of Goods Sold	8 575 000	17 341 000	15 724 000	14 072 000
Salary Costs	43 367 000	41 777 000	24 625 000	22 219 000
Depreciation	3 675 000	3 489 000	2 664 000	2 265 000
Impairment	0	54 000	0	0
Expenditure	84 654 000	86 234 000	60 819 000	50 469 000
Operating Profit	−5 898 000	−3 631 000	−5 390 000	−908 000
Financial Income	5 000	−147 000	9 000	100 000
Financial Costs	485 000	82 000	103 000	414 000
Financial Balance	−480 000	−229 000	−94 000	−314 000
Dividends	0	0	0	0
Net Income	−4 847 000	−2 989 000	−4 281 000	−953 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	74 000
Real Eastate	10 420 000	11 662 000	12 088 000	14 410 000
Machinery and Plant Facilities	9 643 000	13 553 000	9 170 000	6 056 000
Fixtures	3 445 000	634 000	733 000	1 102 000
Total Tangible Assets	23 508 000	25 848 000	21 991 000	21 568 000
Total Fiancial Fixed Assets	13 000	1 071 000	0	0
Total Fixed Assets	23 522 000	26 919 000	21 991 000	21 642 000
Stock	5 844 000	6 321 000	5 384 000	1 036 000
Total Investments	0	0	0	0
Cash, Bank	0	4 138 000	0	1 070 000
Total Current Assets	26 763 000	30 293 000	27 536 000	17 947 000
Total Assets	50 285 000	57 212 000	49 527 000	39 589 000
Total Equity	20 862 000	20 256 000	13 127 000	12 153 000
Short-Term Group Debt	0	0	0	16 953 000
Total Long-Term Debt	421 000	415 000	609 000	330 000
Creditors	3 050 000	625 000	820 000	1 911 000
Unpaid Taxes	4 111 000	3 548 000	2 021 000	3 519 000
Dividends	0	0	0	0
Other Current Debt	21 841 000	32 368 000	32 951 000	4 724 000
Total Current Debt	29 002 000	36 541 000	35 791 000	27 107 000
Total Equity and Debt	50 285 000	57 212 000	49 527 000	39 589 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−23,23 %	−14,76 %	−32,61 %	−7,84 %
Debt-to-Equity Ratio	0,02	0,02	0,05	0,03
Operating Profit Margin	−7,49 %	−4,4 %	−9,72 %	−1,83 %
Current Ratio	0,92	0,83	0,77	0,66
Quick Ratio	1,16	1	0,91	0,69
Equity Ratio	0,41	0,35	0,27	0,31
Gross Profit Margin	89,11 %	79,01 %	71,63 %	71,61 %